AIM ImmunoTech Inc. — Director's Dealing 2019

Dec 16, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AIM ImmunoTech Inc. (AIM)
CIK: 0000946644
Period of Report: 2019-12-13

Reporting Person: RODINO III PETER W. (Dir Govt Relations/Sectry)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-13	Common Stock	A	8381	$0.435	Acquired	51411	Direct

Footnotes

F1: Common Stock Award. Vests in six months, provided continuous employment.